Shares of Moderna rose 6.89% to $149.00 at 15:25 EST on Tuesday, following last session’s downward trend. NASDAQ Composite is rising 1.03% to $13,992.34, following last session’s downward trend, This seems, up until now, an all-around positive trend trading session today.
Moderna’s last close was $139.40, 27.02% under its 52-week high of $189.26.
News about Moderna today
Moderna, biontech stocks surge after regulators halt use of j&j vaccine. According to today’s article on MarketWatch, “Shares of Moderna Inc. shot up 8.6% in morning trading, BioNTech SE ran up 5.7% toward a 4-month high and Pfizer Inc. climbed 1.1% toward a 3-month high, after U.S. health regulators paused the use of Johnson & Johnson’s COVID-19 vaccine price, as the Dow dropped 132 points, or 0.4%. “
Moderna’s sales growth is 28676.7% for the present quarter and 6273.2% for the next. The company’s growth estimates for the ongoing quarter and the next is 1017.1% and 1825.8%, respectively.
Year-on-year quarterly revenue growth grew by 3960.8%, now sitting on 803.4M for the twelve trailing months.
Moderna’s Stock Yearly Top and Bottom Value
Moderna’s stock is valued at $149.00 at 15:25 EST, way below its 52-week high of $189.26 and way higher than its 52-week low of $30.98.
Moderna’s Moving Average
Moderna’s worth is higher than its 50-day moving average of $143.54 and way higher than its 200-day moving average of $119.02.
More news about Moderna.